On this page
F5
coagulation factor V
The F5 gene provides instructions for coagulation factor V, a protein crucial for blood clotting and regulating the coagulation system. The F5 gene encodes coagulation factor V, a protein that plays a central role in haemostasis, the process of blood clot formation.
F5 is located on the long (q) arm of chromosome 1, at band 1q24.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 1 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The F5 gene is responsible for producing coagulation factor V, a vital protein in the complex cascade of blood clotting. This protein helps to form blood clots that seal damaged blood vessels, preventing excessive bleeding and initiating repair processes. Dysfunction of coagulation factor V can disrupt this delicate balance, leading to either an increased risk of clotting or bleeding disorders.
Primarily synthesised by liver cells, coagulation factor V circulates in the bloodstream in an inactive state. It becomes activated following injury, where it interacts with other clotting factors to facilitate the formation of thrombin, a key enzyme in clot development.
What the gene does
The F5 gene provides the blueprint for coagulation factor V, a protein that acts as a cofactor in the blood coagulation pathway. After tissue injury, the inactive factor V is activated into factor Va. Factor Va then complexes with activated factor X (factor Xa) to form the prothrombinase complex. This complex significantly accelerates the conversion of prothrombin to thrombin, which in turn converts fibrinogen into fibrin, forming the meshwork of a blood clot.
Beyond its pro-coagulant role, coagulation factor V also participates in regulating the clotting process. Activated protein C (APC) normally inactivates factor Va by cleaving it at specific sites, thus dampening the clotting response and preventing clots from growing excessively large. This inactivation mechanism is essential for maintaining haemostatic balance and preventing thrombotic events.
Video: Genetics 101
Chromosome location
The F5 gene is located on chromosome 1, specifically within the long arm at position 24.2 (1q24.2). This chromosomal location means the gene resides in a region that has been well-characterised in the human genome.
Protein structure
The coagulation factor V protein is 2224 amino acids long and exhibits a modular structure. It contains two F5/8 type A domains: F5/8 type A 1 (amino acids 30-329) and F5/8 type A 2 (amino acids 348-684). Nested within these are Plastocyanin-like domains, specifically Plastocyanin-like 1 (amino acids 30-193), Plastocyanin-like 2 (amino acids 203-329), Plastocyanin-like 3 (amino acids 348-526), and Plastocyanin-like 4 (amino acids 536-684). A significant B region spans amino acids 692-1573, which includes several disordered regions (amino acids 822-842, 894-927, 982-1001, and 1029-1048, 1097-1157). Within the B region, there are also 2 X 17 AA tandem repeats (amino acids 895-928), specifically 1-1 (amino acids 895-911) and 1-2 (amino acids 912-928).
Key variants
Variants within the F5 gene can alter the function of coagulation factor V, impacting the body's ability to form or regulate blood clots. These genetic changes can affect protein production, modify its activity, or interfere with its inactivation by other regulatory proteins. Such variants are typically inherited in an autosomal dominant pattern.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1258G>T | p.Gly420Cys | Pathogenic | ★★☆☆ | Congenital factor V deficiency |
c.2021del | p.Lys674fs | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital factor V deficiency |
c.2539del | p.Ile847fs | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital factor V deficiency |
c.286G>C | p.Asp96His | Pathogenic | ★★☆☆ | Thrombophilia due to activated protein C resistance |
c.3088C>T | p.Arg1030Ter | Pathogenic | ★★☆☆ | Congenital factor V deficiency |
c.3646G>T | p.Glu1216Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital factor V deficiency |
c.3799del | p.Leu1267fs | Pathogenic/Likely pathogenic | ★★☆☆ | Pregnancy loss, recurrent, susceptibility to, 1 |
c.436C>T | p.Arg146Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital factor V deficiency |
c.4861C>T | p.Arg1621Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital factor V deficiency |
c.4900C>T | p.Arg1634Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Congenital factor V deficiency |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the F5 gene are primarily associated with conditions affecting blood coagulation. The most well-known is Factor V Leiden, which significantly increases the risk of developing abnormal blood clots, a condition known as venous thromboembolism. Other variants can lead to Factor V deficiency, a rare bleeding disorder characterised by insufficient functional coagulation factor V in the blood.
- Factor V Leiden
- Factor V Leiden (heterozygous) Dedicated page coming soon
- Venous thromboembolism Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic F5 variants typically follow autosomal dominant inheritance.
Each child of an affected parent has a 50% chance of inheriting the pathogenic variant, regardless of sex.
UK clinical status
The F5 gene is included on several NHS Genomic Medicine Service panels in the UK, indicating its clinical relevance for genetic testing. These include panels for Bleeding and platelet disorders (R90), Factor V deficiency (R115), Inherited bleeding disorders, and Thrombophilia with a likely monogenic cause (R97).
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main function of the F5 gene?
The F5 gene provides instructions for making coagulation factor V, a protein that plays a critical role in blood clotting. It acts as a cofactor in the formation of thrombin, an enzyme essential for converting fibrinogen into fibrin to form a blood clot.
What is Factor V Leiden?
Factor V Leiden is a specific common variant in the F5 gene. This variant makes coagulation factor V resistant to inactivation by activated protein C (APC), leading to an increased tendency for blood clot formation, known as thrombophilia.
Can F5 gene variants cause bleeding problems?
Yes, some variants in the F5 gene can lead to Factor V deficiency. This condition results in reduced levels or impaired function of coagulation factor V, which can cause a rare bleeding disorder where blood clotting is insufficient.
References
- Cutler JA, Patel R, Rangarajan S. Molecular characterization of 11 novel mutations in patients with heterozygous and homozygous FV deficiency. Haemophilia : the official journal of the World Federation of Hemophilia. 2010. PMID: 20546033
- Asselta R, Peyvandi F. Factor V deficiency. Seminars in thrombosis and hemostasis. 2009. PMID: 19598066
- Rosendorff A, Dorfman DM. Activated protein C resistance and factor V Leiden: a review. Archives of pathology & laboratory medicine. 2007. PMID: 17550313
- Segers K, Dahlbäck B, Nicolaes GA. Coagulation factor V and thrombophilia: background and mechanisms. Thrombosis and haemostasis. 2007. PMID: 17849041
- Vos HL. Inherited defects of coagulation Factor V: the thrombotic side. Journal of thrombosis and haemostasis : JTH. 2006. PMID: 16246256
- Asselta R, Tenchini ML, Duga S. Inherited defects of coagulation factor V: the hemorrhagic side. Journal of thrombosis and haemostasis : JTH. 2006. PMID: 16409445
- Colak Y, Karasu Z, Oruc N. Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome. European journal of gastroenterology & hepatology. 2006. PMID: 16825912
- Brugge JM, Simioni P, Bernardi F. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation. Journal of thrombosis and haemostasis : JTH. 2005. PMID: 16359508
- Duga S, Asselta R, Tenchini ML. Coagulation factor V. The international journal of biochemistry & cell biology. 2004. PMID: 15147718
- Castoldi E, Rosing J. Factor V Leiden: a disorder of factor V anticoagulant function. Current opinion in hematology. 2004. PMID: 15257017
- Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood. 2003. PMID: 12393635
- Ornstein DL, Cushman M. Cardiology patient page. Factor V Leiden. Circulation. 2003. PMID: 12707252
- Nicolaes GA, Dahlbäck B. Factor V and thrombotic disease: description of a janus-faced protein. Arteriosclerosis, thrombosis, and vascular biology. 2002. PMID: 11950687
- Grody WW, Griffin JH, Taylor AK. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genetics in medicine : official journal of the American College of Medical Genetics. 2001. PMID: 11280951
- Janssen HL, Meinardi JR, Vleggaar FP. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000. PMID: 11001884
- Lak M, Sharifian R, Peyvandi F. Symptoms of inherited factor V deficiency in 35 Iranian patients. British journal of haematology. 1998. PMID: 9886321